Welch Group LLC Invests $285,000 in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Welch Group LLC bought a new position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 4,358 shares of the company’s stock, valued at approximately $285,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Allworth Financial LP increased its stake in shares of iShares U.S. Pharmaceuticals ETF by 9.4% in the third quarter. Allworth Financial LP now owns 1,853 shares of the company’s stock worth $131,000 after purchasing an additional 159 shares during the period. Assetmark Inc. lifted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 100.0% during the third quarter. Assetmark Inc. now owns 432 shares of the company’s stock worth $31,000 after buying an additional 216 shares during the last quarter. US Bancorp DE boosted its position in shares of iShares U.S. Pharmaceuticals ETF by 137.0% in the third quarter. US Bancorp DE now owns 384 shares of the company’s stock valued at $27,000 after acquiring an additional 222 shares during the period. Janney Montgomery Scott LLC raised its stake in iShares U.S. Pharmaceuticals ETF by 4.1% during the 4th quarter. Janney Montgomery Scott LLC now owns 6,699 shares of the company’s stock valued at $440,000 after purchasing an additional 261 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its holdings in iShares U.S. Pharmaceuticals ETF by 11.0% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,589 shares of the company’s stock valued at $253,000 after purchasing an additional 356 shares during the period.

iShares U.S. Pharmaceuticals ETF Price Performance

NYSEARCA IHE opened at $69.20 on Tuesday. The company’s fifty day moving average is $67.29 and its two-hundred day moving average is $69.06. The firm has a market capitalization of $698.92 million, a price-to-earnings ratio of 6.49 and a beta of 0.58. iShares U.S. Pharmaceuticals ETF has a 52-week low of $62.67 and a 52-week high of $72.94.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.